Image of Mark Smith

Mark Smith

Chief Financial Officer

Chief Financial Officer at Sion Power Corporation

Tucson, Arizona

Section title

Mark Smith's Email Addresses & Phone Numbers

Mark Smith's Work Experience

Sion Power Corporation

Chief Financial Officer

Tucson, Arizona Area

Annexon Biosciences

Executive Vice President & Chief Financial Officer

January 2018 to May 2019

South San Francisco

Fluidic Energy


October 2013 to January 2016

Scottsdale, Arizona

Mark Smith's Education

University of Canberra

Bachelor's degree, Accounting

1979 to 1982

Mark Smith's Professional Skills Radar Chart

Based on our findings, Mark Smith is ...


What's on Mark Smith's mind?

Based on our findings, Mark Smith is ...

44% Left Brained
56% Right Brained

Mark Smith's Estimated Salary Range

About Mark Smith's Current Company

Sion Power Corporation

Frequently Asked Questions about Mark Smith

What company does Mark Smith work for?

Mark Smith works for Sion Power Corporation

What is Mark Smith's role at Sion Power Corporation?

Mark Smith is Chief Financial Officer

What is Mark Smith's personal email address?

Mark Smith's personal email address is ma****[email protected]

What is Mark Smith's business email address?

Mark Smith's business email address is m****[email protected]

What is Mark Smith's Phone Number?

Mark Smith's phone (602) ***-*136

What industry does Mark Smith work in?

Mark Smith works in the Renewables & Environment industry.

Who are Mark Smith's colleagues?

Mark Smith's colleagues are Yery Silitonga, Ika Girsang, Ashutosh Singh, and Mario Jimenez

About Mark Smith

📖 Summary

Chief Financial Officer @ Sion Power Corporation Tucson, Arizona AreaExecutive Vice President & Chief Financial Officer @ Annexon Biosciences From January 2018 to May 2019 (1 year 5 months) South San FranciscoCFO @ Fluidic Energy From October 2013 to January 2016 (2 years 4 months) Scottsdale, ArizonaChief Financial Officer @ Calimmune, Inc Calimmune was successfully sold to CSL Behring, part of CSL, for $91M upfront with up to $325M in potential future milestone payments effective August 31, 2017. From February 2016 to October 2017 (1 year 9 months) Tucson, Arizona AreaCFO @ Neuromedical Systems Technology sold to Autocyte (subsequently consolidated into Tripath Imaging and transacted to Becton Dickenson) From February 1998 to August 1999 (1 year 7 months) Upper Saddle River, New JerseyGroup Contoller @ Genzyme Initially served as VP Finance for Genzyme Genetics following that business unit's acquisiton of Genetrix where I served as CFO. From March 1996 to February 1998 (2 years) Cambridge, MassachusettsCFO @ Genetrix Sold company to Genzyme in a transaction consolidating significant genetic testing companies. I transferred to Genzyme as the VP Finance for the Genzyme Genetics business unit. From June 1991 to March 1996 (4 years 10 months) Audit Manager @ Price Waterhouse Coopers Commenced career with Price Waterhouse Sydney (Group 3 Audit). After qualifying as a Chartered Accountant in 1986, I transferred to San Jose California. From January 1983 to June 1991 (8 years 6 months) CFO @ Gevo Successfully completed IPO in February 2011 raising proceeds of $123MGevo is a renewable chemicals and next generation biofuels company. Our overall strategy is to commercialize biobased alternatives to petroleum-based products using a combination of synthetic biology and chemical technology. In order to implement this strategy, we are taking a building block approach. Initially, we intend to produce and sell isobutanol from renewable feedstocks. Isobutanol is a four carbon alcohol that can be sold directly for use as a specialty chemical in the production of solvents, paints, and coatings or as a value-added fuel blendstock. Isobutanol can also be converted into butenes using straightforward dehydration chemistry deployed in the refining and petrochemicals industries today. The convertibility of isobutanol into butenes is important because butenes are primary hydrocarbon building blocks used in the production of lubricants, rubber, plastics, fibers, other polymers and hydrocarbon fuels. We believe that the products derived from isobutanol have potential applications in approximately 40% of the global petrochemicals market, representing a potential market for isobutanol of approximately 70 billion gallons per year (“BGPY”), and substantially all of the global hydrocarbon fuels market, representing a potential market for isobutanol of approximately 900 BGPY. From November 2008 to October 2013 (5 years) Englewood, ColoradoCFO @ Replidyne, Inc. Recruited to provide financial leadership to IPO that was successfully completed in June 2006.Played leadership role in strategic sale of company to Cardiovascular Systems Inc. that was completed in February 2009 From March 2006 to February 2009 (3 years) Louisville, ColoradoCFO @ Nabi Biopharmaceuticals Chief Financial Officer from April 2001 to March 2006Led several major financings including raising $112 million in a convertible debt transaction in a private transaction utilizing Form 144a (April/May 2005), raising net $91 million in a follow on secondary offering enhancing the company’s institutional investor base while providing the financial resources to complete clinical trials of primary development stage product and raising $32 million in Private Investment in a Public Entity raising funds for strategic acquisition of a product line, Played leadership role in acquisition of strategic product line Negotiated debt agreement to provide financial resources for working capital through product development cycle and strategic product acquisitionPlayed leadership role in developing corporate strategy shifting focus to biotechnology business following sale of legacy operations focused on plasma salesPlayed leadership role in disposition of a legacy business unit completing the company’s transition into a fully integrated biopharmaceutical companyLed process of initial compliance with Sarbanes Oxley Act, Section 404Responsible for finance, treasury, risk management, business development and SEC reporting maintaining responsibility as Principal Accounting OfficerFrequently meet with key investors and potential investors on behalf of the company, delivered company investor presentation at investor conferences and maintained primary relationship with investment bankers and advisers From August 1999 to March 2006 (6 years 8 months) Boca Raton, Florida

Mark Smith’s Personal Email Address, Business Email, and Phone Number

are curated by ContactOut on this page.

10x your recruitment & sales conversations

Contact over 200M professionals
instantly by email or phone. Reveal
personal & work email addresses, as
well as phone numbers accurately with
our ContactOut Chrome extension.

In a nutshell

Mark Smith's Personality Type

Extraversion (E), Sensing (S), Thinking (T), Perceiving (P)

Average Tenure

3 year(s), 8 month(s)

Mark Smith's Willingness to Change Jobs



Open to opportunity?

There's 93% chance that Mark Smith is seeking for new opportunities

Mark Smith's Social Media Links

/company/s... /school/un...
Engage candidates 10x faster

Enjoy unlimited access and discover candidates outside of LinkedIn

Trusted by 400K users from

76% of Fortune 500 companies

Microsoft Nestle PWC JP Morgan Merck Rackspace WarnerMedia Randstad Yelp Google

The most accurate data ever

CCPA Compliant
GDPA Aligned
150M Personal Emails
300M Work Emails
50M Direct Dials
200M Professional Profiles
30M Company Profiles

Hire Anyone, Anywhere
with ContactOut today

Making remote or global hires? We can help.

  • 50 contacts/month
  • Works on standard LinkedIn only
  • Work emails, personal emails, mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free